Zobrazeno 1 - 10
of 9 084
pro vyhledávání: '"alcoholic steatohepatitis"'
Autor:
Qianyi Wan, Xingzhu Liu, Jinghao Xu, Rui Zhao, Shiqin Yang, Jianrong Feng, Zhan Cao, Jingru Li, Xiaopeng He, Haiou Chen, Jinbao Ye, Haiyang Chen, Yi Chen
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 6, Pp 2608-2617 (2024)
ABSTRACT Background Obesity is a significant risk factor for the progression of non‐alcoholic fatty liver disease (NAFLD). However, a convenient and efficacious non‐invasive test for monitoring NAFLD progression in patients with obesity is curren
Externí odkaz:
https://doaj.org/article/6078186f72fb4a3586f4a8656745cd93
Autor:
Cyrin Annie Cyriac, Geeta Achutha Panicker, Sojan George Kunnathuparambil, Steffin Mathai Kattoor
Publikováno v:
Journal of Clinical and Scientific Research, Vol 13, Iss 3, Pp 165-169 (2024)
Background: This study aimed to evaluate the utility of various blood parameters in predicting oesophageal varices in patients with cirrhosis of liver. Methods: In this retrospective study, laboratory parameters like platelet count, haemoglobin level
Externí odkaz:
https://doaj.org/article/3a0ee5cfa2cc4255a1ecb0e46ef5721c
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 20, Iss 6, Pp 436-442 (2024)
Background. The relevance of finding optimal methods to treat patients with a comorbid non-alcoholic steatohepatitis (NASH) that developed against the background of type 2 diabetes mellitus (T2DM) is due to the fact that these diseases have a number
Externí odkaz:
https://doaj.org/article/2fefccdb33a04776b81c2ca36f9bc56e
Autor:
Prashasti Gupta
Publikováno v:
Indian Journal of Community Medicine, Vol 49, Iss 6, Pp 780-785 (2024)
Non-alcoholic fatty liver disease (NAFLD), a major cause of chronic liver disease, is known to affect a quarter of the global adults. Natural history of NAFLD shows interindividual variation, traditionally it progresses from simple steatosis to steat
Externí odkaz:
https://doaj.org/article/dcb67348287541d4bc3d5cc7148158e9
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 34, Iss 237, Pp 1-13 (2024)
Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is one of the most common metabolic diseases worldwide. Asprosin has been identified as a novel adipokine closely associated with hepatic glucose metabolism, but limited information is
Externí odkaz:
https://doaj.org/article/20717f26d04147359f70f928dbb5f1bd
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Non-alcoholic fatty liver diseases (NAFLDs)/non-alcoholic steatohepatitis (NASH) are the most common liver disorders among patients with type 2 diabetes. Newer classes of glucose-lowering agents (GLAs), such as glucagon-like pepti
Externí odkaz:
https://doaj.org/article/30dd7f7150754683ae4a5cd14846afb7
Autor:
Alaa Ahmed Abd El Hamid, Azza Emam Mohamed, Manal sabry Mohamed, Ghada Essam El-Din Amin, Hagar Ahmed Ahmed Elessawy, Mohamed Farouk Allam
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic fat accumulation (> 5% of liver tissue) in the absence of alcohol abuse or other chronic liver diseases. NAFLD can progress to non-alcoholic steatohepatitis (NA
Externí odkaz:
https://doaj.org/article/aa128202a84b43fcb810d9db00567b17
Autor:
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Calina, Javad Sharifi-Rad
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-15 (2024)
Abstract Metabolic dysfunction-associated steatohepatitis (MASH) and progression to hepatocellular carcinoma (HCC) exhibits distinct molecular and immune characteristics. These traits are influenced by multiple factors, including the gut microbiome,
Externí odkaz:
https://doaj.org/article/9c8a6e1968304acb827c35e2b77b729e
Autor:
Huan Zhang, Yongqiang He, Yuqing Zhao, Malina Axinbai, Yuwei Hu, Shilei Liu, Jingmin Kong, Jinhui Sun, Liping Zhang
Publikováno v:
Hereditas, Vol 161, Iss 1, Pp 1-14 (2024)
Abstract Background The most common progressive form of non-alcoholic fatty liver disease (NAFLD) is non-alcoholic steatohepatitis (NASH), which is characterized by the development of cirrhosis, and requires liver transplantation. We screened for the
Externí odkaz:
https://doaj.org/article/8effe56cc7ed4c52ba08d6782c5a87e5
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 20, Iss 5, Pp 375-382 (2024)
Background. Non-alcoholic steatohepatitis (NASH) in individuals with type 2 diabetes mellitus (T2DM) is considered a comorbid condition with an unfavorable prognosis and a significant economic burden on the global healthcare system. Despite patient
Externí odkaz:
https://doaj.org/article/a385e9590f8b4d7e9d7f28f1d3db35c8